title: Amphetamine acts within the lateral hypothalamic area to elicit affectively neutral arousal and reinstate drug-seeking.
abstract: Psychostimulants, including amphetamine (AMPH), exert robust arousal-enhancing, reinforcing and locomotor-activating effects. These behavioural actions involve drug-induced elevations in extracellular norepinephrine (NE) and dopamine (DA) within a variety of cortical and subcortical regions. The lateral hypothalamic area (LHA), including the lateral hypothalamus proper, perifornical area and adjacent dorsomedial hypothalamus, is implicated in appetitive- and arousal-related processes. The LHA is innervated by both NE and DA projections and systemically administered AMPH has been demonstrated to activate LHA neurons. Combined, these and other observations suggest the LHA may be a site of action in the behavioural effects of psychostimulants. To test this hypothesis, we examined the degree to which AMPH (10 nmol, 25 nmol) acts within the LHA to exert arousing, locomotor-activating and reinforcing actions in quietly resting/sleeping rats. Although intra-LHA AMPH robustly increased time spent awake, this occurred in the absence of pronounced locomotor activation or reinforcing actions, as measured in a conditioned place preference (CPP) paradigm. Arousing and stressful conditions or drug re-exposure can elicit relapse in humans and reinstate drug-seeking in animals. Given the LHA is also implicated in the reinstatement of drug-seeking behaviour, additional studies examined whether AMPH acts within the LHA to reinstate an extinguished CPP produced with systemic AMPH administration. Our results demonstrate that AMPH action within the LHA is sufficient to reinstate drug-seeking behaviour, as measured in this paradigm. Collectively, these observations demonstrate that psychostimulants act within the LHA to elicit affectively neutral arousal and reinstate drug-seeking behaviour.
authors.affiliation: Department of Psychology, University of Wisconsin, Madison, WI 53706, USA.
authors.forename: Brooke E
authors.initials: BE
authors.lastname: Schmeichel
authors.forename: Craig W
authors.initials: CW
authors.lastname: Berridge
mesh_terms: D000661:Amphetamine / Q000008:administration & dosage / Q000494:pharmacology*; D000818:Animals; D001143:Arousal / Q000187:drug effects*; D058256:Brain Waves / Q000187:drug effects; D000697:Central Nervous System Stimulants / Q000008:administration & dosage / Q000494:pharmacology; D058999:Drug-Seeking Behavior / Q000187:drug effects*; D005108:Extinction, Psychological / Q000187:drug effects; D007026:Hypothalamic Area, Lateral / Q000187:drug effects*; D008297:Male; D008845:Microinjections; D009043:Motor Activity / Q000187:drug effects; D051381:Rats
chemical_list: D000697:Central Nervous System Stimulants; D000661:Amphetamine
references.citation: Brain Res Rev. 2009 Mar;59(2):253-77
references.pmid: 18762212
references.citation: Proc Natl Acad Sci U S A. 1999 Sep 14;96(19):10911-6
references.pmid: 10485925
references.citation: Mol Pharmacol. 2005 Aug;68(2):421-9
references.pmid: 15890841
references.citation: J Neurosci. 1996 Nov 1;16(21):6999-7009
references.pmid: 8824336
references.citation: Psychopharmacology (Berl). 2001 Dec;158(4):343-59
references.pmid: 11797055
references.citation: Neuroscience. 2008 Jun 2;153(4):1225-34
references.pmid: 18436386
references.citation: J Neurosci. 2002 Jul 1;22(13):5713-8
references.pmid: 12097523
references.citation: Behav Neurosci. 2001 Feb;115(1):165-74
references.pmid: 11256440
references.citation: Physiol Rev. 1962 Oct;42:554-604
references.pmid: 13939938
references.citation: Annu Rev Public Health. 2010;31:385-98
references.pmid: 20070191
references.citation: J Neurosci. 1991 Sep;11(9):2703-12
references.pmid: 1715389
references.citation: Psychopharmacology (Berl). 1989;97(1):59-64
references.pmid: 2496428
references.citation: Nature. 2005 Sep 22;437(7058):556-9
references.pmid: 16100511
references.citation: Cell Mol Life Sci. 2008 May;65(10):1475-88
references.pmid: 18351292
references.citation: J Comp Neurol. 2003 Sep 15;464(2):220-37
references.pmid: 12898614
references.citation: Neuropsychopharmacology. 2006 Nov;31(11):2332-40
references.pmid: 16855535
references.citation: Brain Res Bull. 1992 Aug;29(2):247-54
references.pmid: 1356069
references.citation: Neuropsychopharmacology. 2007 Jul;32(7):1433-51
references.pmid: 17164822
references.citation: Eur J Neurosci. 1994 Mar 1;6(3):293-8
references.pmid: 7912614
references.citation: Cell Mol Life Sci. 2012 Feb;69(4):581-97
references.pmid: 21947443
references.citation: Psychol Rev. 1954 Jan;61(1):5-22
references.pmid: 13134413
references.citation: J Physiol. 2012 Aug 15;590(16):3677-89
references.pmid: 22641785
references.citation: Neuroscience. 2001;106(4):699-715
references.pmid: 11682157
references.citation: BMC Neurosci. 2006 May 30;7:43
references.pmid: 16734896
references.citation: Neuron. 2000 Sep;27(3):469-74
references.pmid: 11055430
references.citation: J Neurosci. 2002 Aug 1;22(15):6742-6
references.pmid: 12151553
references.citation: Brain Res Rev. 2008 Jun;58(1):1-17
references.pmid: 18199483
references.citation: J Pharmacol Exp Ther. 1997 Aug;282(2):561-73
references.pmid: 9262316
references.citation: Eur J Pharmacol. 1991 Mar 5;194(2-3):189-94
references.pmid: 2060599
references.citation: Trends Neurosci. 2006 Oct;29(10):571-7
references.pmid: 16904760
references.citation: Neuroscience. 1999;93(3):885-96
references.pmid: 10473254
references.citation: J Comp Neurol. 2006 Feb 10;494(5):845-61
references.pmid: 16374809
references.citation: J Neurosci. 2002 Apr 1;22(7):2873-84
references.pmid: 11923452
references.citation: Proc Natl Acad Sci U S A. 2005 Dec 27;102(52):19168-73
references.pmid: 16357203
references.citation: Brain Res. 2010 Feb 16;1314:103-11
references.pmid: 19948148
references.citation: J Neurosci. 2001 Mar 1;21(5):1656-62
references.pmid: 11222656
references.citation: Psychopharmacology (Berl). 1988;96(4):521-7
references.pmid: 2907662
references.citation: Psychopharmacology (Berl). 2000 Dec;153(1):31-43
references.pmid: 11255927
references.citation: Neuropsychopharmacology. 2010 Jan;35(1):217-38
references.pmid: 19710631
references.citation: Eur J Neurosci. 2000 May;12(5):1705-13
references.pmid: 10792448
references.citation: Behav Brain Res. 2000 Oct;115(1):39-47
references.pmid: 10996406
references.citation: Life Sci. 1983 Dec 19;33(25):2551-7
references.pmid: 6645814
references.citation: Biol Psychiatry. 2013 May 1;73(9):843-50
references.pmid: 23312563
references.citation: Arch Gen Psychiatry. 1974 Apr;30(4):539-47
references.pmid: 4131353
references.citation: J Physiol. 2013 Apr 1;591(7):1951-66
references.pmid: 23318871
references.citation: Eur J Neurosci. 2005 Aug;22(3):697-705
references.pmid: 16101751
references.citation: J Neurosci. 1998 Apr 1;18(7):2729-39
references.pmid: 9502830
references.citation: J Stud Alcohol. 1995 Sep;56(5):538-45
references.pmid: 7475034
references.citation: J Neurosci. 2001 Mar 1;21(5):1787-94
references.pmid: 11222668
references.citation: Neuropsychopharmacology. 1990 Jun;3(3):153-62
references.pmid: 2141985
references.citation: J Pharmacol Exp Ther. 2003 Oct;307(1):386-94
references.pmid: 12944496
references.citation: Brain Res Brain Res Rev. 2000 Aug;33(1):13-33
references.pmid: 10967352
references.citation: Eur J Neurosci. 2013 Mar;37(6):891-900
references.pmid: 23252935
references.citation: Lancet. 2000 Jan 1;355(9197):39-40
references.pmid: 10615891
references.citation: Psychol Rev. 2004 Jan;111(1):33-51
references.pmid: 14756584
references.citation: Eur J Pharmacol. 1999 Jun 30;375(1-3):13-30
references.pmid: 10443561
references.citation: Neuroscience. 2003;121(1):201-17
references.pmid: 12946712
references.citation: Brain Res. 1992 Aug 14;588(1):104-14
references.pmid: 1327405
references.citation: Brain Res. 2002 Jul 12;943(2):224-36
references.pmid: 12101045
references.citation: Eur J Neurosci. 2005 May;21(10):2807-16
references.pmid: 15926928
references.citation: J Pharmacol Exp Ther. 1997 Aug;282(2):591-6
references.pmid: 9262319
references.citation: Addiction. 2010 Jun;105(6):991-1002
references.pmid: 20659059
references.citation: Brain Res. 2010 Feb 16;1314:74-90
references.pmid: 19815001
references.citation: J Psychiatry Neurosci. 2000 Mar;25(2):125-36
references.pmid: 10740986
references.citation: Synapse. 2002 Jan;43(1):51-61
references.pmid: 11746733
references.citation: Neuroscience. 2008 Jan 24;151(2):313-9
references.pmid: 18055123
references.citation: Eur J Pharmacol. 1985 Oct 22;116(3):221-8
references.pmid: 3878298
references.citation: Neurosci Lett. 2005 Oct 21;387(2):80-4
references.pmid: 16084021
references.citation: J Pharmacol Exp Ther. 2012 Mar;340(3):801-9
references.pmid: 22186370
references.citation: Science. 1975 Oct 31;190(4213):475-7
references.pmid: 1166317
references.citation: Brain Res. 1998 Apr 20;790(1-2):185-94
references.pmid: 9593886
references.citation: Synapse. 2002 Dec 1;46(3):140-9
references.pmid: 12325041
references.citation: Eur J Neurosci. 2000 Feb;12(2):726-30
references.pmid: 10712652